Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRO40303 for Reduction of Reperfusion Injury in AMI
NCT01374321Phase 2Completed
- Sponsor
- Roche
- Start
- Oct 2011
- Primary completion
- Sep 2013
- Modality
- Small Molecules
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial in acute myocardial infarction (AMI) comparing TRO40303 Arm with Placebo Arm (2 arms). Primary endpoint: Infarct size expressed as area under the curve for Creatine kinase and Troponin I at 72 hours. Started Oct 2011; status: completed.
02
Drugs
TRO40303
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT01374321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01374321.